The new institute plans to use structured clinical information to inform targeted testing in order to cut down the time to diagnosis.
The company said the divestiture to Varian Medical Systems would allow it to concentrate on investing in high-growth parts of its business.
In Science this week: imaging approach to visual epigenetic activity in the brain, and more.
A research team from Stanford University modified single-molecule microscopy to see nanoscale details of DNA.
The deal joins Systems Imagination's integrative genomic and multi-scalar data-analysis services with 3Scan's 3D reconstructive tissue imaging technology.
Groups receiving funding will be part of a Consortium for Imaging and Biomarkers to perform collaborative studies, share ideas, and leverage common resources.
The partners will provide drug discovery services, expertise, and infrastructure in a new AMRI center located in the Buffalo Medical Innovation and Commercialization Hub.
It is KromaTid's second international distribution deal for its genomic imaging and FISH assays.
The partners will explore the feasibility of combining medical imaging data with genomic and clinical data to inform disease diagnosis.
Genetic and imaging data support the idea that lower-than-usual levels of the tumor suppressor gene PTEN can drive the formation of some ovarian cancers.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.